Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Microglia are the principal immune cells of the brain. In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques. However, the role of microglia in Alzheimer disease has not been resolved. Microglia may be neuroprotective by phagocytosing amyloid-beta (Abeta), but their activation and the secretion of neurotoxins may also cause neurodegeneration. Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation. Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576). Alzheimer disease mice deficient in Ccr2 accumulated Abeta earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Abeta clearance and increased mortality. Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Abeta clearance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The protective function of Ly6Clo monocytes in AD may also explain why CCR2 deficiency exacerbates disease severity [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“CCR2 deficiency worsened AD pathology [89, 238]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“studies utilizing whole body irradiation chimeras, an experimental technique that is now recognized to condition the brain for monocyte infiltration [2, 3, 230], as well as transplant of BM-derived cells, reported that Ly6Chi monocytes infiltrate the AD mouse brain and accumulate around Aβ plaques.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“These infiltrating cells were thought to ameliorate disease evolution by phagocytosis and clearance of Aβ from the brain parenchyma [287] or by promotion of CCR2-mediated microglial accumulation in amyloid plaques and degradation of Aβ [89].”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [89]
In the citing paper
“Marrow-derived cells may have an ameliorative effect on neurodegenerative phenotypes in mice33,34, possibly due to their superior phagocytic capacity35.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [34]
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are chemotactic cytokines that bind specific G protein–coupled receptors on the surface of cells and mediate the accumulation of leukocytes at sites of inflammatio”
BackgroundBard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Cited by
Items 301–400 of 940
Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 89
Towards Retinoid Therapy for Alzheimers Disease
Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91
“One of the chemokine receptors, CCR2 deficiency impairs microglial accumulation and accelerates the progression of AD-like disease in a model mouse, Tg2576 [41, 54].”
BackgroundThe Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
Azizi, G., Hossein‐Khannazer, N., & Mirshafiey, A. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518651 · Cited by 103
CD45 Deficiency Drives Amyloid-β Peptide Oligomers and Neuronal Loss in Alzheimer's Disease Mice
Zhu, Y., Hou, H., Rezai-Zadeh, K. P., Giunta, B. N., Ruscin, A., Gemma, C., Jin, J., Dragicevic, N., Bradshaw, P. C., Rasool, S., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3268-10.2011 · Cited by 99
Zhang, K., Tian, L., Liu, L., Feng, Y., Dong, Y.-B., Li, B., Shang, D.-S., Fang, W.-G., Cao, Y.-P., & Chen, Y.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072744 · Cited by 86
The contribution of the peripheral immune system to neurodegeneration
Berriat, F., Lobsiger, C. S., & Boillée, S. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01323-6 · Cited by 87
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 88
Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration
Au, N. P. B., & Ma, C. H. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00128 · Cited by 86
Weisman, G. A., Camden, J. M., Peterson, T. S., Ajit, D., Woods, L. T., & Erb, L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8263-z · Cited by 100
Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
Choi, S.-H., & Bosetti, F. (2009) · Aging · doi:10.18632/aging.100021 · Cited by 84
Matousek, S. B., Ghosh, S., Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., & O’Banion, M. K. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9331-2 · Cited by 86
“Alternatively, IL-1 overexpression may increase recruitment of peripheral myeloid cells, which have been implicated in plaque clearance (Simard et al. 2006; El Khoury et al. 2007).”
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair
Schwartz, M., & Raposo, C. (2014) · The Neuroscientist · doi:10.1177/1073858413516799 · Cited by 86
Age exacerbates the CCR2/5-mediated neuroinflammatory response to traumatic brain injury
Morganti, J. M., Riparip, L., Chou, A., Liu, S., Gupta, N. M., & Rosi, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0547-1 · Cited by 89
Tzeng, T.-T., Chen, C.-C., Chen, C., Tsay, H.-J., Lee, L., Chen, W.-P., Shen, C.-C., & Shiao, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020598 · Cited by 92
The problem of genotype and sex differences in life expectancy in transgenic AD mice
Rae, E. A., & Brown, R. E. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.002 · Cited by 89
The Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
The immune system in traumatic brain injury
Plesnila, N. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.008 · Cited by 86
Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84
Murine models of Alzheimer's disease and their use in developing immunotherapies
Wısnıewskı, T., & Sigurdsson, E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.004 · Cited by 90
Functional alterations of myeloid cells during the course of Alzheimer’s disease
Thome, A. D., Faridar, A., Beers, D. R., Thonhoff, J. R., Zhao, W., Wen, S., Pascual, B., Masdeu, J. C., & Appel, S. H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0293-1 · Cited by 83
Circular compartmentalized microfluidic platform: Study of axon–glia interactions
Hosmane, S., Yang, I. H., Ruffin, A., Thakor, N. V., & Venkatesan, A. (2010) · Lab on a Chip · doi:10.1039/b918640a · Cited by 83
Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 91
Ryu, J. K., Cho, T., Choi, H. B., Jantaratnotai, N., & McLarnon, J. G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0339-z · Cited by 80
Systemic infection modifies the neuroinflammatory response in late stage Alzheimer’s disease
Rakić, S., Hung, Y. M. A., Smith, M., So, D., Tayler, H. M., Varney, W., Wild, J., Harris, S., Holmes, C., Love, S., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0592-3 · Cited by 100
Zhou, F., Sun, Y., Xie, X., & Zhao, Y. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01254-1 · Cited by 83
β-Arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology
Liu, X., Zhao, X., Zeng, X., Bossers, K., Swaab, D. F., Zhao, J., & Pei, G. (2013) · Cell Research · doi:10.1038/cr.2012.167 · Cited by 80
Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
Santiago, A. R., Baptista, F. I., Santos, P. F., Cristóvão, G., Ambrósio, A. F., Cunha, R. A., & Gomes, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/465694 · Cited by 93
Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Yokoyama, I., Mosley, R. L., & Gendelman, H. E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.009 · Cited by 80
Hickman, S. E., Allison, E. K., Coleman, U., Kingery-Gallagher, N. D., & El Khoury, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02780 · Cited by 80
Self-citationMicroglia and Synapse: Interactions in Health and Neurodegeneration
Šišková, Z., & Tremblay, M.-È. (2013) · Neural Plasticity · doi:10.1155/2013/425845 · Cited by 80
Sato, E., Shick, H. E., Ransohoff, R. M., & Hirose, K. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21583 · Cited by 84
Migration of blood cells to β-amyloid plaques in Alzheimer's disease
Hohsfield, L. A., & Humpel, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.002 · Cited by 79
“…PM C Funders A uthor M anuscripts E urope PM C Funders A uthor M anuscripts mononuclear phagocytes (i.e., microglia/blood-derived monocytes) to lesion sites, impairs the accumulation of these cells near Aβ plaques and accelerates Aβ plaque burden in AD transgenic mice (El Khoury et al., 2007).”
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 83
Naert, G., & Rivest, S. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00306 · Cited by 83
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease
Guedes, J. R., Santana, I. J., Cunha, C., Duro, D., Almeida, M. R., Cardoso, A. M., de Lima, M. C. P., & Cardoso, A. L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.004 · Cited by 82
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
Jin, L., Lucente, J. D., Nguyen, H. M., Singh, V., Singh, L., Chavez, M., Bushong, T., Wulff, H., & Maezawa, I. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.754 · Cited by 72
Bone marrow-derived macrophages from aged rats are more responsive to inflammatory stimuli
Barrett, J. P., Costello, D. A., O’Sullivan, J., Cowley, T. R., & Lynch, M. A. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0287-7 · Cited by 76
“the CNS, and this was associated with increased Aβ plaque burden and mortality [48].”
BackgroundPoon, C. H., Wang, Y., Fung, M.-L., Zhang, C., & Lim, L. W. (2020) · Aging and disease · doi:10.14336/ad.2019.1026 · Cited by 73
Qu, C. F., Li, Q., Su, Z., Ip, S., Yuan, Q., Xie, Y., Xu, Q., Yang, W., Huang, Y., Xian, Y., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.03.012 · Cited by 80
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
Paouri, E., Tzara, O., Kartalou, G.-I., Zenelak, S., & Georgopoulos, S. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2484-16.2017 · Cited by 76
Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment
Imbimbo (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00019 · Cited by 75
Autoimmune and inflammatory mechanisms of CNS damage
Kapadia, M., & Šakić, B. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.008 · Cited by 81
Why Did Tarenflurbil Fail in Alzheimer's Disease?
Imbimbo, B. P. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1092 · Cited by 85
Microglia Ontology and Signaling
ElAli, A., & Rivest, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00072 · Cited by 72
Munawara, U., Catanzaro, M., Xu, W., Tan, C., Hirokawa, K., Bosco, N., Dumoulin, D., Khalil, A., Larbi, A., Lévesque, S., et al. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00236-x · Cited by 74
Jungbauer, L. M., Yu, C., Laxton, K. J., & LaDu, M. J. (2009) · Journal of Molecular Recognition · doi:10.1002/jmr.948 · Cited by 73
Neuroimmune contributions to Alzheimer’s disease: a focus on human data
Haage, V., & De Jager, P. L. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01637-0 · Cited by 74
Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain
Biber, K. P. H., & Boddeke, E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00210 · Cited by 76
Stöhr, O., Schilbach, K., Moll, L., Hettich, M. M., Freude, S., Wunderlich, F. T., Ernst, M. B., Zemva, J., Brüning, J. C., Krone, W., et al. (2011) · AGE · doi:10.1007/s11357-011-9333-2 · Cited by 83
Alzheimer’s Disease and ncRNAs
Maoz, R., Garfinkel, B. P., & Soreq, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_18 · Cited by 78
Koronyo-Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2020) · Brain · doi:10.1093/brain/awz364 · Cited by 70
Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model
Reed-Geaghan, E. G., Croxford, A. L., Becher, B., & Landreth, G. E. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191374 · Cited by 72
Li, T., Zhao, J., Xie, W., Yuan, W., Guo, J., Pang, S., Gan, W.-B., Gómez-Nicola, D., & Zhang, S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02127-w · Cited by 72
The role of the immune system in driving neuroinflammation
Ní Chasaide, C., & Lynch, M. A. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212819901082 · Cited by 72
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot-Sestier, M.-V., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72
Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
Kantarci, A., Tognoni, C. M., Yaghmoor, W., Marghalani, A., Stephens, D., Ahn, J.-Y., Carreras, I., & Dedeoglu, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75517-4 · Cited by 66
Involvement of TRPC Channels in CCL2-Mediated Neuroprotection against Tat Toxicity
Yao, H., Peng, F., Dhillon, N. K., Callen, S. E., Bokhari, S. M., Stehno‐Bittel, L., Ahmad, S. O., Wang, J. Q., & Buch, S. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2781-08.2009 · Cited by 72
Jellinger, K. A., Janetzky, B., Attems, J., & Kienzl, E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00313.x · Cited by 85
Wang, X., & Li, L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.722028 · Cited by 75
The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology
Lau, S.-F., Wu, W., Wong, H. Y., Ouyang, L., Qiao, Y., Xu, J., Lau, J. H.-Y., Wong, C., Jiang, Y., Holtzman, D. M., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00491-1 · Cited by 70
A nasal proteosome adjuvant activates microglia and prevents amyloid deposition
Frenkel, D., Puckett, L., Petrovic, S., Xia, W., Chen, G., Vega, J., Dembinsky‐Vaknin, A., Shen, J., Plante, M., Burt, D. S., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21340 · Cited by 56
Ikezu, S., & Ikezu, T. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00033 · Cited by 79
Thomson, C. A., McColl, A., Graham, G. J., & Cavanagh, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01759-8 · Cited by 76
Corona, A. W., Kodoma, N., Casali, B. T., & Landreth, G. E. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9627-8 · Cited by 65
Takamatsu, K., Ikeda, T., Haruta, M., Matsumura, K., Ogi, Y., Nakagata, N., Uchino, M., Ando, Y., Nishimura, Y., & Senju, S. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.10.001 · Cited by 68
Joseph, J., Mecca, A. P., Regenhardt, R. W., Bennion, D. M., Rodríguez, V., Desland, F. A., Patel, N., Pioquinto, D. J., Unger, T., Katovich, M. J., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.044 · Cited by 70
Microglia in Alzheimer’s Disease
Li, Y., Tan, M., Jiang, T., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/437483 · Cited by 81
Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice
Xie, K., Liu, Y., Hao, W., Walter, S., Penke, B., Hartmann, T., Schachner, M., & Fassbender, K. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.013 · Cited by 72
Kiyota, T., Yamamoto, M., Schroder, B., Jacobsen, M. T., Swan, R. J., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · Molecular Therapy · doi:10.1038/mt.2009.44 · Cited by 75
Shang, D. S., Yang, Y. M., Zhang, H., Tian, L., Jiang, J. S., Dong, Y. B., Zhang, K., Li, B., Zhao, W. D., Fang, W. G., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16660983 · Cited by 69
Popiołek-Barczyk, K., Ciechanowska, A., Ciapała, K., Pawlik, K., Oggioni, M., Mercurio, D., Simoni, M. G. D., & Mika, J. (2020) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2020.101671 · Cited by 76
Urrutia, P. J., Hirsch, É. C., González-Billault, C. E., & Núñez, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14005 · Cited by 70
Beckmann, N., Gérard, C., Abramowski, D., Cannet, C., & Staufenbiel, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4936-10.2011 · Cited by 66
Muñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01530-z · Cited by 66
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 73
Zhang, X., Wang, B., O'Callaghan, P. W., Hjertström, E., Jia, J., Gong, F., Zcharia, E., Nilsson, L. N. G., Lannfelt, L., Vlodavsky, I., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0997-1 · Cited by 70
Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology
Obulesu, M., & Jhansilakshmi, M. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.831852 · Cited by 67
Edison, P., & Brooks, D. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179929 · Cited by 65
Crespo‐Castrillo, A., & Arévalo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093219 · Cited by 72
Huang, W.-C., Yen, F.-C., Shie, F., Pan, C., Shiao, Y.-J., Yang, C.-N., Huang, F.-L., Sung, Y. J., & Tsay, H. J. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-28 · Cited by 70
Passos, G. F., Figueiredo, C. P., Prediger, R. D., Pandolfo, P., Duarte, F. S., Medeiros, R., & Calixto, J. Β. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081113 · Cited by 69
Chemokines and their receptors: orchestrating a fine balance between health and disease
Sharma, M. (2009) · Critical Reviews in Biotechnology · doi:10.1080/07388550903187418 · Cited by 67
Qu, W., Johnson, A., Kim, J. H., Lukowicz, A., Svedberg, D., & Cvetanovic, M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0880-z · Cited by 68
Manji, Z., Rojas, A., Wang, W., Dingledine, R., Varvel, N. H., & Ganesh, T. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180678 · Cited by 60
Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
Liu, Z., Li, H., & Pan, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.658323 · Cited by 72
How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Rezai-Zadeh, K. P., Gate, D., Gowing, G., & Town, T. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256017 · Cited by 65
Kata, D., Földesi, I., Fehér, L. Z., Hackler, L., Puskás, L. G., & Gulya, K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.053 · Cited by 68
Innate Immune Functions of Astrocytes are Dependent Upon Tumor Necrosis Factor-Alpha
Rodgers, K. R., Lin, Y., Langan, T. J., Iwakura, Y., & Chou, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63766-2 · Cited by 77
Fletcher, E. L., Downie, L. E., Hatzopoulos, K. M., Vessey, K. A., Ward, M. M., Chow, C., Pianta, M. J., Vingrys, A. J., Kalloniatis, M., & Wilkinson‐Berka, J. L. (2009) · Documenta Ophthalmologica · doi:10.1007/s10633-009-9193-6 · Cited by 64
Inflammation and Microglia Actions in Alzheimer’s Disease
Combs, C. K. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9165-3 · Cited by 70
Dogs with Cognitive Dysfunction Syndrome: A Natural Model of Alzheimer’s Disease
Bosch, M. N., Pugliese, M., Gimeno‐Bayón, J., Rodríguez, M. J., & Mahy, N. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107546 · Cited by 65
Woodling, N. S., & Andreasson, K. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00016 · Cited by 63
Minogue, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.008 · Cited by 65
Song, C., Furuoka, H., Kim, C.-L., Ogino, M., Suzuki, A., Hasebe, R., & Horiuchi, M. (2008) · Journal of General Virology · doi:10.1099/vir.0.83578-0 · Cited by 62
Pan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis
Pedicone, C., Fernandes, S., Dungan, O. M., Dormann, S. M., Viernes, D. R., Adhikari, A. A., Choi, L. B., De Jong, E. P., Chisholm, J. D., & Kerr, W. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.238030 · Cited by 61
Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Zuena, A. R., Casolini, P., Lattanzi, R., & Maftei, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00622 · Cited by 60
Kyrkanides, S., Miller, A. W., Miller, J. H., Tallents, R. H., Brouxhon, S. M., Olschowka, M. E., O’Banion, M. K., & Olschowka, J. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.024 · Cited by 65
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Ghosh, S., & Geahlen, R. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.09.053 · Cited by 59
Gómez‐Nicola, D., Schetters, S. T. T., & Hugh Perry, V. (2014) · Glia · doi:10.1002/glia.22660 · Cited by 60
Metadata
- Authors
- El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D.
- Affiliations
- Okayama University (JP)
- Northwestern University (US)
- Corresponding author
- Luster, Andrew D
- Venue
- Nature Medicine
- Published
- 2007-03-11
- Volume
- 13
- Issue
- 4
- Pages
- 432-438
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2097867538
- Cited by
- 915
- References
- 51
- Citations by year
- 2026: 29 · 2025: 27 · 2024: 41 · 2023: 35 · 2022: 44 · 2021: 70 · 2020: 51 · 2019: 37 · 2018: 42 · 2017: 51 · 2016: 51 · 2015: 60 · 2014: 43 · 2013: 53 · 2012: 70
- FWCI
- 34.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- Dana Foundation
- Gladstone Institutes
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- CCR2, chemokine receptors, microglia, Alzheimer's disease, amyloid-beta clearance, Tg2576 mice, disease progression, neuroinflammation, gene dosage, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Brain, Crosses, Genetic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Immunohistochemistry, Monocytes, Amyloid beta-Peptides, Microglia, Mice, Knockout, Models, Immunological, Chemokines, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.